tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ASRT Stock Latest News

Is ASRT a Buy, Before Earnings?
Pre-EarningsIs ASRT a Buy, Before Earnings?
1d ago
ASRT
Assertio Therapeutics Announces New CEO Appointment
PremiumCompany Announcements
Assertio Therapeutics Announces New CEO Appointment
10d ago
8K
ASRT
Assertio CEO Brendan O’Grady to depart, Mark Reisenauer to succeed
PremiumThe Fly
Assertio CEO Brendan O’Grady to depart, Mark Reisenauer to succeed
12d ago
ASRT
Assertio Therapeutics Amends ROLVEDON Supply Agreement
PremiumCompany Announcements
Assertio Therapeutics Amends ROLVEDON Supply Agreement
30d ago
8K
ASRT
Assertio Therapeutics’ Growth Potential Driven by Sympazan and Stable Revenue Streams
PremiumRatings
Assertio Therapeutics’ Growth Potential Driven by Sympazan and Stable Revenue Streams
2M ago
ASRT
Buy Rating Affirmed for Assertio Therapeutics Amid Positive Sympazan Study and Strong Financial Outlook
PremiumRatingsBuy Rating Affirmed for Assertio Therapeutics Amid Positive Sympazan Study and Strong Financial Outlook
2M ago
ASRT
Assertio presents new data from study of SYMPAZAN Oral Film
Premium
The Fly
Assertio presents new data from study of SYMPAZAN Oral Film
2M ago
ASRT
Assertio Therapeutics’ Earnings Call: Mixed Sentiments and Strategic Shifts
Premium
Company Announcements
Assertio Therapeutics’ Earnings Call: Mixed Sentiments and Strategic Shifts
2M ago
ASRT
Assertio price target lowered to $3 from $3.50 at H.C. Wainwright
PremiumThe Fly
Assertio price target lowered to $3 from $3.50 at H.C. Wainwright
3M ago
ASRT
Assertio Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Assertio Therapeutics Reports Q2 2025 Financial Results
3M ago
ASRT
Is ASRT a Buy, Before Earnings?
PremiumPre-Earnings
Is ASRT a Buy, Before Earnings?
3M ago
ASRT
Assertio Therapeutics: Buy Rating Affirmed Amid Strong ROLVEDON Growth and Positive Financial Outlook
PremiumRatings
Assertio Therapeutics: Buy Rating Affirmed Amid Strong ROLVEDON Growth and Positive Financial Outlook
6M ago
ASRT
Assertio Therapeutics’ Earnings Call: Mixed Results and Strategic Plans
PremiumCompany AnnouncementsAssertio Therapeutics’ Earnings Call: Mixed Results and Strategic Plans
6M ago
ASRT
Assertio Therapeutics Approves Key Proposals at Annual Meeting
Premium
Company Announcements
Assertio Therapeutics Approves Key Proposals at Annual Meeting
6M ago
8K
ASRT
Assertio price target lowered to $1.50 from $1.75 at Alliance Global Partners
Premium
The Fly
Assertio price target lowered to $1.50 from $1.75 at Alliance Global Partners
6M ago
ASRT
Assertio Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Assertio Therapeutics Reports Q1 2025 Financial Results
6M ago
ASRT
Is ASRT a Buy, Before Earnings?
PremiumPre-Earnings
Is ASRT a Buy, Before Earnings?
6M ago
ASRT
Assertio Therapeutics: Balancing Short-term Challenges with Long-term Optimism and Strategic Growth Initiatives
PremiumRatings
Assertio Therapeutics: Balancing Short-term Challenges with Long-term Optimism and Strategic Growth Initiatives
8M ago
ASRT
Assertio Holdings price target lowered to $3.50 from $4 at H.C. Wainwright
PremiumThe Fly
Assertio Holdings price target lowered to $3.50 from $4 at H.C. Wainwright
8M ago
ASRT
Assertio Therapeutics: Strategic Growth and Financial Resilience Amidst Market Volatility
PremiumRatingsAssertio Therapeutics: Strategic Growth and Financial Resilience Amidst Market Volatility
8M ago
ASRT
Assertio price target lowered to $1.75 from $2.15 at Alliance Global
Premium
The Fly
Assertio price target lowered to $1.75 from $2.15 at Alliance Global
8M ago
ASRT
Assertio Therapeutics’ Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Assertio Therapeutics’ Earnings Call: Growth Amid Challenges
8M ago
ASRT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >